-
Baudax Bio's Preoperative Med Associated With Pain Reduction, Lower Opioids Use In Patients After Knee Replacement
Monday, April 26, 2021 - 10:05am | 252Read More...Baudax Bio Inc (NASDAQ: BXRX) has announced the online publication of Phase 3b study data highlighting the safety and efficacy of preoperative Anjeso (meloxicam) injection in patients undergoing unilateral total knee arthroplasty (TKA) when used within a multimodal analgesic...
-
ConforMIS Surges 9% Following Clinical Study Updates
Wednesday, March 30, 2016 - 2:06pm | 240Read More...Shares of ConforMIS Inc (NASDAQ: CFMS), a medical technology company, were trading higher by 9 percent by mid-Wednesday afternoon after the company announced positive results from several clinical studies. ConforMIS stated the results from the studies will be fully presented at the 2016 British...
